Quantitative model for efficient temporal targeting of tumor cells and neovasculature.
Kohandel, M., Haselwandter, C.A., Kardar, M., Sengupta, S., Sivaloganathan, S. (2011)
Computational & Mathematical Methods in Medicine
Similarity:
Displaying similar documents to “Modelling the Impact of Pericyte Migration and Coverage of Vessels on the Efficacy of Vascular Disrupting Agents”
Quantitative model for efficient temporal targeting of tumor cells and neovasculature.
Multiscale modelling of tumour growth and therapy: the influence of vessel normalisation on chemotherapy.
Alarcón, Tomás, Owen, Markus R., Byrne, Helen M., Maini, Philip K. (2006)
Computational & Mathematical Methods in Medicine
Similarity:
Targeting tumour vasculature as a cancer treatment.
Honstvet, Christopher.A., Jones, Pamela F. (2007)
Computational & Mathematical Methods in Medicine
Similarity:
The non-uniform spatial development of a micrometastasis.
Bloor, Malcolm I.G., Wilson, Michael J. (1999)
Journal of Theoretical Medicine
Similarity:
Lymphangiogenesis.
Tait, Catherine R., Jones, Pamela F. (2003)
Journal of Theoretical Medicine
Similarity:
A mathematical model of a micrometastasis.
Bloor, Malcolm I.G., Wilson, Michael J. (1997)
Journal of Theoretical Medicine
Similarity:
Development and validation of a mathematical model to describe anti-cancer prodrug activation by antibody-enzyme conjugates.
Jackson, Trachette L., Senter, Peter D., Murray, James D. (2000)
Journal of Theoretical Medicine
Similarity:
Modeling the Impact of Anticancer Agents on Metastatic Spreading
S. Benzekry, N. André, A. Benabdallah, J. Ciccolini, C. Faivre, F. Hubert, D. Barbolosi (2012)
Mathematical Modelling of Natural Phenomena
Similarity:
Treating cancer patients with metastatic disease remains an ultimate challenge in clinical oncology. Because invasive cancer precludes or limits the use of surgery, metastatic setting is often associated with (poor) survival, rather than sustained remission, in patients with common cancers like lung, digestive or breast carcinomas. Mathematical modeling may help us better identify non detectable metastatic status to in turn optimize treatment...